Guangdong Provincial People's Hospital: Breast Neoplasms trials

The registry lists 20 Breast Neoplasms studies with Guangdong Provincial People's Hospital as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 13Phase 3 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral NeuropathyRecruitingNCT07410169Phase 2/3
• Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast CancerNot yet recruitingNCT07077018Not applicable
• A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer PatientsNot yet recruitingNCT06825975Not applicable
• A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer PatientsNot yet recruitingNCT06825949Not applicable
• A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer PatientsRecruitingNCT06811870Phase 1/2
• Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or Cannot be Surgically RemovedNot yet recruitingNCT06547476Phase 2
• Organoid-based Functional Precision Therapy for Advanced Breast CancerRecruitingNCT06102824Phase 2
• Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)RecruitingNCT04858529Phase 3
• Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast CancerNot yet recruitingNCT04858516Phase 2
• Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node BiopsyCompletedNCT04951245Phase 3
• MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast CancerCompletedNCT04909554
• Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel ChemotherapyCompletedNCT04637308Phase 2
• TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast CancerStatus unknownNCT04094896Phase 2
• Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast CancerStatus unknownNCT03507465Phase 2/3
• Neoadjuvant Endocrine Therapy in Breast CancerCompletedNCT03397537Phase 2
• Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast CancerCompletedNCT03243838Phase 2
• Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor TherapyCompletedNCT03162133Not applicable
• DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast CancerCompletedNCT03154749Phase 2
• TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast CancerCompletedNCT03140553Phase 2
• Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerStatus unknownNCT02059876Phase 2